Delivery Order SPE2DB24D1205-SPE2DB25FDADA
Award Date 9/4/25
Potential Completion Date 9/25/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $17,153.19 delivery order to AmerisourceBergen Drug Corp for Yervoy (ipilimumab) 50 mg/10 mL vials on August 21, 2025, with an ultimate completion date of September 12, 2025. This non-competitive delivery order operates under a firm fixed price structure and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Yervoy is a checkpoint inhibitor immunotherapy commonly used in cancer treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $22,870.92 to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials on July 2, 2025, with completion targeted for July 24, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order performed at the contractor's facility in Conshohocken, Pennsylvania. Yervoy is a specialized immunotherapy pharmaceutical used in oncology treatment, reflecting the critical role AmerisourceBergen plays in...
- The Defense Logistics Agency awarded a $49,957.75 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Yervoy 200 mg/40 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child delivery order under AmerisourceBergen's...
- The U.S. Department of Defense's Medical Supply Chain awarded a $22,957.99 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Yervoy 200 mg/40 mL vials. This competitive award, with an ultimate completion date of August 19, 2025, represents a firm fixed-price contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. Yervoy (ipilimumab) is an immunotherapy...
- The Defense Logistics Agency awarded a delivery order valued at $11,435.46 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Yervoy 50 mg/10 ml vials. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 20, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Yervoy (ipilimumab) 50 mg/10 mL vials, with a contract ceiling value of $11,435.46. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Yervoy 50 mg/10 mL vials with a ceiling value of $11,435.46 under a firm fixed-price contract type. This non-set-aside award represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The delivery is scheduled to be completed...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,963.34 firm fixed-price contract is for the delivery of Yervoy 50 mg/10 ml vials, a medication used in the treatment of certain types of cancer. The order has a completion date of June 5, 2025. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $36,457.87 to AmerisourceBergen Drug Corp for YERVOY (ipilimumab) 200 mg/40 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract was awarded on August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,870.92 to AmerisourceBergen Drug Corp for the supply of Yervoy 50 mg/10 mL vials. This firm fixed-price delivery order, issued on September 5, 2025, represents a competitively awarded procurement with no set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order, leveraging its established...